Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

19 results
Display

Recurrent Psychosis after Phentermine Administration in a Young Female: A Case Report

Jo HS, Wang SM, Kim JJ

Phentermine is a sympathomimetic amine, like amphetamine, which is one of the most often prescribed drugs for weight loss. Although exact mechanism of phentermine causing psychosis is still not clear,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Intoxication with Phentermine

Ku JE, Joo YS, You JS, Chung SP, Lee HS

  • KMID: 2025763
  • J Korean Soc Clin Toxicol.
  • 2014 Jun;12(1):35-38.
Phentermine has been widely used as an appetite suppressant since 2004 in Korea. The authors experienced two cases of acute phentermine overdose and report with the literature review. A 36-year-old...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phentermine, Sibutramine and Affective Disorders

An H, Sohn H, Chung S

  • KMID: 2171190
  • Clin Psychopharmacol Neurosci.
  • 2013 Apr;11(1):7-12.
A safe and effective way to control weight in patients with affective disorders is needed, and phentermine is a possible candidate. We performed a PubMed search of articles pertaining to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Phentermine Hydrochloride Induced Acute Myopia and Acute Angle Closure

Koo SH, Choi WS, Lee JW, Park YJ, Lee KW

PURPOSE: To describe a case of bilateral acute myopia and acute angle-closure associated with phentermine hydrochloride, a drug used for obesity treatment. CASE SUMMARY: A 25-year-old woman visited our hospital with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intracerebral Hemorrhage related to Phentermine as an Appetite Suppressant

Lee WJ, Kang MK, Shin HR, Kim TJ, An SJ, Mo H, Nam K, Yoon BW

We present a case report indicating that the administration of phentermine, an appetite suppressant with sympathomimetic activity, can provoke an intracerebral hemorrhage. A 48-year-old woman with no previously established cerebrovascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pulmonary Hypertension Associated with Use of Phentermine

Bang WD, Kim JY, Yu HT, Cho SS, Jang JY, Oh CM, Joung B, Chang HJ

Weight-control drugs (known as anorexigens) such as fenfluramine have been linked with pulmonary hypertension in previous reports. In our case, a 29 year old woman was admitted for shortness of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Psychotic Disorder Induced by Appetite Suppressants, Phentermine or Phendimetrazine: A Case Series Study

Kwak S, Youn T, Lee NY, Chung IW, Kim SH

OBJECTIVES: A retrospective case series study was conducted to investigate the clinical characteristics of psychotic disorders induced by appetite suppressants, phentermine and phendimetrazine. METHODS: A retrospective electronic medical record review identified...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Phentermine for Obese Patients: A Preliminary Open-Label Study

Park YW

  • KMID: 2078198
  • Korean J Obes.
  • 2005 Mar;14(1):1-8.
BACKGROUND: Phentermine, an anti-obesity drug which has been used for more than 40 years in the United States, was recently introduced in Korea. There is no article about phentermine for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
RE: Pulmonary Hypertension Associated with Use of Phentermine?

Hendricks , Rothman RB

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects on Weight Reduction and Safety of Short-Term Phentermine Administration in Korean Obese People

Kim KK, Cho HJ, Kang HC, Youn BB, Lee KR

The phentermine, an appetite suppressant, has been widely applied in Korea since 2004. However, there have been relatively few reports about the efficacy and the safety of phentermine in Korea....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Double-blind, Parallel-group, Placebo-controlled Multi-center Clinical Trial for Evaluating the Efficacy and Safety of Phentermine Hydrochloride in Obese Patients

Choi CJ, Kim KS, Kim SR, Kang JH, Park HS

  • KMID: 1992543
  • Korean J Obes.
  • 2005 Sep;14(3):155-162.
BACKGROUND: Phentermine is a sympathomimetic amine used as an appetite suppressant for short term therapy. The aim of this study is to evaluate the efficacy and safety of phentermine in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacotherapy for Obesity

Joo JK, Lee KS

Obesity is an important risk factor for metabolic disease and various cancers. Treatments of obesity include lifestyle intervention, pharmacotherapy, and bariatric surgery. If weight loss with lifestyle intervention is only...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug Therapy for Obesity

Kim KS, Park SW

  • KMID: 2270999
  • Korean J Obes.
  • 2012 Dec;21(4):197-202.
Obesity is associated with a substantial increase in metabolic disorders and various cancers. As weight loss achieved with lifestyle intervention is modest, there is a need for drug treatment. Orlistat, phentermine,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity

Kim HO, Lee JA, Suh HW, Kim YS, Kim BS, Ahn ES, Roh YJ, Jung SG, Kim JM, Kang MK, Ahn IS, Park YG

BACKGROUND: Obesity is a complex problem that is now considered a chronic metabolic disease. In Korea, phentermine has been widely used for the treatment of obesity in the primary care...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model

Go RE, Hwang KA, Kim SH, Lee MY, Kim CW, Jeon SY, Kim YB, Choi KC

According to WHO global estimates from 2008, more than 1.4 billion adults were overweight and among them, over 200 million men and 300 million women were obese. Although the main...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Behavioral Intervention and Anti-Obesity Drug Therapy

Kim MK

  • KMID: 2267840
  • Korean J Med.
  • 2013 May;84(5):624-628.
Obesity is associated with a reduction in life expectancy and an increase in mortality from cardiovascular diseases, cancer, and other causes. The U.S. Preventive Service Task Force (USPSTF) recommends screening...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Weight Loss Drugs Recently Approved by the FDA

Lee CB

There have been many advances in obesity treatment, including life-style modification and pharmacological and surgical treatments. It seems that the most remarkable advances in obesity treatment are those of pharmacological...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacotherapy for obesity

Kim KK

Due to its serious comorbidities and high prevalence, obesity is one of the heaviest burdens for public health. Although diet, exercise and behavioral modification are the first-line treatment for obesity,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Drugs for Obesity Treatment

Kim WJ, Lee CB

There have recently been many advances in obesity treatment, including lifestyle modifications and pharmacological and surgical treatments. Specifically, pharmacological strategies have improved significantly. However, the history of the development of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr